Skip to main content
eScholarship
Open Access Publications from the University of California

DIVERGENT ACTIVITY OF AFATINIB (AFAT) AND CETUXIMAB (CET) IN PATIENT-DERIVED XENOGRAFT (PDX) MODELS OF ACQUIRED ERLOTINIB RESISTANCE.

  • Author(s): Mack, P
  • Goodwin, N
  • Holland, W
  • Kelly, K
  • Li, T
  • Lara, P
  • Gandara, D
  • et al.
Main Content
Current View